Artykuły w czasopismach na temat „LNCaP cell line”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „LNCaP cell line”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Yanish, Yu V., M. P. Prylutskyi, I. O. Sumnikova, et al. "THE INFLUENCE OF SPERMINE AND CHLORHEXIDINE ON THE SURVIVAL, ELECTROKINETIC AND CYTOMORPHOLOGICAL CHARACTERISTICS OF HUMAN PROSTATE CANCER CELLS." Oncology 25, no. 3 (2023): 186–93. http://dx.doi.org/10.15407/oncology.2023.03.186.
Pełny tekst źródłaKim, Sang Soo, Hee Joo Cho, Jung Yoon Kang, Hee Kyu Kang, and Tag Keun Yoo. "Inhibition of Androgen Receptor Expression with Small Interfering RNA Enhances Cancer Cell Apoptosis by Suppressing Survival Factors in Androgen Insensitive, Late Stage LNCaP Cells." Scientific World Journal 2013 (2013): 1–8. http://dx.doi.org/10.1155/2013/519397.
Pełny tekst źródłaLima, Thiago S., Diego Iglesias-Gato, Luciano D. O. Souza, et al. "Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance." Cancers 13, no. 6 (2021): 1290. http://dx.doi.org/10.3390/cancers13061290.
Pełny tekst źródłaGuillemette, Chantal, and Alain Bélanger. "Glucuronosyltransferase activity in human cancer cell line LNCaP." Molecular and Cellular Endocrinology 107, no. 2 (1995): 131–39. http://dx.doi.org/10.1016/0303-7207(94)03434-u.
Pełny tekst źródłaRuokonen, Minna, Jing-Dong Shan, Pirjo Hedberg, Lila Patrikainen, and Pirkko Vihko. "Transfecting Well-Differentiated Prostatic Cancer Cell Line LNCaP." Biochemical and Biophysical Research Communications 218, no. 3 (1996): 794–96. http://dx.doi.org/10.1006/bbrc.1996.0141.
Pełny tekst źródłaSeki, Taiga, Yui Shimizu, Kyota Ishii, Yuzuki Takahama, Kazunori Kato, and Tomohiro Yano. "NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway." Biomolecules 11, no. 11 (2021): 1702. http://dx.doi.org/10.3390/biom11111702.
Pełny tekst źródłaYanish, Yu V., M. P. Prylutskyi, O. K. Voronina, and S. P. Zaletok. "THE INFLUENCE OF SPERMINE AND AMINOGUANIDINE ON THE MORPHOFUNCTIONAL CHARACTERISTICS OF HUMAN PROSTATE CANCER CELL LINE LNCaP." Oncology 25, no. 1 (2023): 24–31. http://dx.doi.org/10.15407/oncology.2023.01.024.
Pełny tekst źródłaKang, Minyong, Chang Wook Jeong, Kyoung-Hwa Lee, Ja Hyeon Ku, Hyeon Hoe Kim, and Cheol Kwak. "Histone demethylase KDM7a to control androgen receptor activity in hormone-sensitive prostate cancer." Journal of Clinical Oncology 35, no. 6_suppl (2017): 262. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.262.
Pełny tekst źródłaMohtashami, Leila, Narjes Ghows, Zahra Tayarani-Najaran, and Mehrdad Iranshahi. "Galbanic Acid-Coated Fe3O4 Magnetic Nanoparticles with Enhanced Cytotoxicity to Prostate Cancer Cells." Planta Medica 85, no. 02 (2018): 169–78. http://dx.doi.org/10.1055/a-0721-1886.
Pełny tekst źródłaAbate-Shen, Cory, and Francisca Nunes de Almeida. "Establishment of the LNCaP Cell Line – The Dawn of an Era for Prostate Cancer Research." Cancer Research 82, no. 9 (2022): 1689–91. http://dx.doi.org/10.1158/0008-5472.can-22-1065.
Pełny tekst źródłaVeldscholte, Jos, Cor A. Berrevoets, and Eppo Mulder. "Studies on the human prostatic cancer cell line LNCaP." Journal of Steroid Biochemistry and Molecular Biology 49, no. 4-6 (1994): 341–46. http://dx.doi.org/10.1016/0960-0760(94)90277-1.
Pełny tekst źródłaInoue, Takahiro, Toru Yoshida, Yosuke Shimizu та ін. "Requirement of Androgen-Dependent Activation of Protein Kinase Cζ for Androgen-Dependent Cell Proliferation in LNCaP Cells and Its Roles in Transition to Androgen-Independent Cells". Molecular Endocrinology 20, № 12 (2006): 3053–69. http://dx.doi.org/10.1210/me.2006-0033.
Pełny tekst źródłaZuhrotun, Ade, Rizky Abdullah, Meiliana Thamrin, and Resti Febriliza. "Antitumor Activity of Soursop (Annona muricata L.) Leaves On Prostate Cancer Cell Line." Acta Pharmaceutica Indonesia 38, no. 2 (2013): 43–47. http://dx.doi.org/10.5614/api.v38i2.5208.
Pełny tekst źródłaSluka, P., G. Whitty, and I. D. Davis. "Stimulation of prostate cancer cell proliferation by bone-derived factors." Journal of Clinical Oncology 29, no. 7_suppl (2011): 32. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.32.
Pełny tekst źródłaIshii, Kenichiro, Kazuhiro Iguchi, Chise Matsuda, Yoshifumi Hirokawa, Yoshiki Sugimura, and Masatoshi Watanabe. "Application of Original Prostate Cancer Progression Model Interacting with Fibroblasts in Preclinical Research." Journal of Clinical Medicine 13, no. 24 (2024): 7837. https://doi.org/10.3390/jcm13247837.
Pełny tekst źródłaIshii, Kenichiro, Takeshi Sasaki, Kazuhiro Iguchi, et al. "Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G1 Cell Cycle Arrest." Journal of Clinical Medicine 8, no. 1 (2019): 44. http://dx.doi.org/10.3390/jcm8010044.
Pełny tekst źródłaDahiya, Rajvir, Bryan Boyle, Beth Carol Goldberg, et al. "Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines." Biochemistry and Cell Biology 70, no. 7 (1992): 548–54. http://dx.doi.org/10.1139/o92-085.
Pełny tekst źródłaSehgal, I., J. Bailey, K. Hitzemann, M. R. Pittelkow, and N. J. Maihle. "Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells." Molecular Biology of the Cell 5, no. 3 (1994): 339–47. http://dx.doi.org/10.1091/mbc.5.3.339.
Pełny tekst źródłaZafari, Jaber, Hossein Abbasinia, Hediyeh Gharehyazi, Fatemeh Javani Jouni, Saeed Jamali, and Mohammadreza Razzaghi. "Evaluation of Biological Activity of Different Wavelengths of Low-Level Laser Therapy on the Cancer Prostate Cell Line Compared With Cisplatin." Journal of Lasers in Medical Sciences 12, no. 1 (2021): e17-e17. http://dx.doi.org/10.34172/jlms.2021.17.
Pełny tekst źródłaKojoeiyan Jafari, Nasim, Hossein Vazini, and Mohammad Taghi Goodarzi. "The Oxidative and Cytotoxic Effects of Resveratrol Compared With Cisplatin in the LNCap Prostate Cancer Cell Line." International Journal of Basic Science in Medicine 7, no. 2 (2022): 61–68. http://dx.doi.org/10.34172/ijbsm.2022.11.
Pełny tekst źródłaPolek, Tara C., LaMonica V. Stewart, Elizabeth J. Ryu, Michael B. Cohen, Elizabeth A. Allegretto, and Nancy L. Weigel. "p53 Is Required for 1,25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells." Endocrinology 144, no. 1 (2003): 50–60. http://dx.doi.org/10.1210/en.2001-210109.
Pełny tekst źródłaPhongsuwichetsak, Chayisara, Thummaruk Suksrichavalit, Chawalit Chatupheeraphat, Warawan Eiamphungporn, Sakda Yainoy, and Vichanan Yamkamon. "Diospyros rhodocalyx Kurz induces mitochondrial-mediated apoptosis via BAX, Bcl-2, and caspase-3 pathways in LNCaP human prostate cancer cell line." PeerJ 12 (July 1, 2024): e17637. http://dx.doi.org/10.7717/peerj.17637.
Pełny tekst źródłavan Steenbrugge, G. J., M. Groen, J. W. van Dogen, et al. "The human prostatic carcinoma cell line LNCaP and its derivatives." Urological Research 17, no. 2 (1989): 71–77. http://dx.doi.org/10.1007/bf00262024.
Pełny tekst źródłaNegri-Cesi, Paola, and Marcella Motta. "Androgen metabolism in the human prostatic cancer cell line LNCaP." Journal of Steroid Biochemistry and Molecular Biology 51, no. 1-2 (1994): 89–96. http://dx.doi.org/10.1016/0960-0760(94)90119-8.
Pełny tekst źródłaYanish, Yu V., S. P. Zaletok, O. K. Voronina, et al. "THE EFFECT OF PARGILINE, SPERMINE AND THEIR COMBINATIONS ON ANDROGEN-DEPENDENT AND ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER CELLS in vitro." Oncology 26, no. 3 (2024): 186–96. http://dx.doi.org/10.15407/oncology.2024.03.186.
Pełny tekst źródłaLeung, Pak-Shan, William J. Aronson, Tung H. Ngo, Lawrence A. Golding, and R. James Barnard. "Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro." Journal of Applied Physiology 96, no. 2 (2004): 450–54. http://dx.doi.org/10.1152/japplphysiol.00871.2003.
Pełny tekst źródłaSanmukh, Swapnil Ganesh, Nilton José dos Santos, Caroline Nascimento Barquilha, et al. "Bacteriophages M13 and T4 Increase the Expression of Anchorage-Dependent Survival Pathway Genes and Down Regulate Androgen Receptor Expression in LNCaP Prostate Cell Line." Viruses 13, no. 9 (2021): 1754. http://dx.doi.org/10.3390/v13091754.
Pełny tekst źródłaFurlan, Tobias, Florian Handle, Marcus V. Cronauer, and Frédéric R. Santer. "Abstract 2686: Is ARV7 a regulator of prostate cancer stemness and plasticity." Cancer Research 82, no. 12_Supplement (2022): 2686. http://dx.doi.org/10.1158/1538-7445.am2022-2686.
Pełny tekst źródłaSalemi, Michele, Filippo Fraggetta, Antonio Galia, et al. "Cerebellar Degeneration-Related Autoantigen 1 (CDR1) Gene Expression in Prostate Cancer Cell Lines." International Journal of Biological Markers 29, no. 3 (2014): 288–90. http://dx.doi.org/10.5301/jbm.5000062.
Pełny tekst źródłaMora-Rodríguez, José María, Belén G. Sánchez, Alba Sebastián-Martín, et al. "Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications." International Journal of Molecular Sciences 24, no. 21 (2023): 15626. http://dx.doi.org/10.3390/ijms242115626.
Pełny tekst źródłaBAI, GE, SUSAN KASPER, ROBERT J. MATUSIK, PAUL S. RENNIE, JEFFREY A. MOSHIER, and ARNON KRONGRAD. "Androgen Regulation of the Human Ornithine Decarboxylase Promoter in Prostate Cancer Cells." Journal of Andrology 19, no. 2 (1998): 127–35. http://dx.doi.org/10.1002/j.1939-4640.1998.tb01981.x.
Pełny tekst źródłaEmamgholipour, Zahra, Zeinab Hami-Saravani, Heshmatollah Ebrahimi-Najafabadi, Hamidreza Hoveida, and Sara Dabirian. "Designing a Temporin-1CEa Analog with Improved in Vitro Selectivity towards Prostate Cancerous Cell Line (LNCaP)." Acta Scientiarum. Technology 46, no. 1 (2024): e67217. http://dx.doi.org/10.4025/actascitechnol.v46i1.67217.
Pełny tekst źródłaRaitanen, Julia, Bernadette Barta, Marcus Hacker, Dietmar Georg, Theresa Balber, and Markus Mitterhauser. "Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines." Cells 12, no. 3 (2023): 360. http://dx.doi.org/10.3390/cells12030360.
Pełny tekst źródłaSzyszka, Marta, Lukasz Paschke, Marianna Tyczewska, et al. "Analysis of Transcriptome, Selected Intracellular Signaling Pathways, Proliferation and Apoptosis of LNCaP Cells Exposed to High Leptin Concentrations." International Journal of Molecular Sciences 20, no. 21 (2019): 5412. http://dx.doi.org/10.3390/ijms20215412.
Pełny tekst źródłaFr�nsdal, Katrine, Nikolai Engedal, and Fahri Saatcioglu. "Efficient DNA-mediated gene transfer into prostate cancer cell line LNCaP." Prostate 43, no. 2 (2000): 111–17. http://dx.doi.org/10.1002/(sici)1097-0045(20000501)43:2<111::aid-pros5>3.0.co;2-4.
Pełny tekst źródłaSpans, Lien, Zeynep Kalender Atak, Filip Van Nieuwerburgh, et al. "Variations in the exome of the LNCaP prostate cancer cell line." Prostate 72, no. 12 (2011): 1317–27. http://dx.doi.org/10.1002/pros.22480.
Pełny tekst źródłaLeith, John T. "In vitro radiation sensitivity of the lncap prostatic tumor cell line." Prostate 24, no. 3 (1994): 119–24. http://dx.doi.org/10.1002/pros.2990240304.
Pełny tekst źródłaPousette, Åke, Kjell Carlström, Peter Henriksson, Mirtha Grande, and Reinhard Stege. "Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research." Prostate 31, no. 3 (1997): 198–203. http://dx.doi.org/10.1002/(sici)1097-0045(19970515)31:3<198::aid-pros9>3.0.co;2-h.
Pełny tekst źródłaNurmikko, Pauliina, Ville Väisänen, Timo Piironen, Sari Lindgren, Hans Lilja, and Kim Pettersson. "Production and Characterization of Novel Anti-Prostate-specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA." Clinical Chemistry 46, no. 10 (2000): 1610–18. http://dx.doi.org/10.1093/clinchem/46.10.1610.
Pełny tekst źródłaGao, Bei, Hui-Wen Lue, Jennifer Podolak, et al. "Multi-Omics Analyses Detail Metabolic Reprogramming in Lipids, Carnitines, and Use of Glycolytic Intermediates between Prostate Small Cell Neuroendocrine Carcinoma and Prostate Adenocarcinoma." Metabolites 9, no. 5 (2019): 82. http://dx.doi.org/10.3390/metabo9050082.
Pełny tekst źródłaDahut, Madeline, Kristen Fousek, Lucas Horn, Haiyan Qin, Jeffrey Schlom, and Claudia Palena. "727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (2021): A757. http://dx.doi.org/10.1136/jitc-2021-sitc2021.727.
Pełny tekst źródłaChen, Qi, Zhi-kang Cai, Yan-bo Chen, et al. "Poly r(C) Binding Protein-1 is Central to Maintenance of Cancer Stem Cells in Prostate Cancer Cells." Cellular Physiology and Biochemistry 35, no. 3 (2015): 1052–61. http://dx.doi.org/10.1159/000373931.
Pełny tekst źródłaÖzgönül, Ali Mert, Aycan Aşık, Burak Durmaz, Ramin Aslaminabad, Cumhur Gündüz, and Eser Yıldırım Sozmen. "Antiproliferative effect of rosehip tea phenolics in prostate cancer cell lines." Turkish Journal of Biochemistry 45, no. 4 (2020): 423–28. http://dx.doi.org/10.1515/tjb-2019-0262.
Pełny tekst źródłaRunge, Roswitha, Anne Naumann, Matthias Miederer, Joerg Kotzerke, and Claudia Brogsitter. "Up-Regulation of PSMA Expression In Vitro as Potential Application in Prostate Cancer Therapy." Pharmaceuticals 16, no. 4 (2023): 538. http://dx.doi.org/10.3390/ph16040538.
Pełny tekst źródłaTsvetankova, Radostina, Ilka Tsvetkova, Albena Apostolova, Soren Hayrabedyan, and Krassimira Todorova. "Combined microRNA-141 Rescue and MAPK1 Silencing as Putative Strategy to Support Chemotherapy in Translational Stage towards Metastatic Castration-resistant Prostate Cancer – an In Vitro Model Study." Proceedings of the Bulgarian Academy of Sciences 76, no. 8 (2023): 1286–96. http://dx.doi.org/10.7546/crabs.2023.08.15.
Pełny tekst źródłaGuerriero, Ilaria, Håkon Ramberg, Krizia Sagini, Manuel Ramirez-Garrastacho, Kristin A. Taskén та Alicia Llorente. "Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells". PLOS ONE 16, № 6 (2021): e0253828. http://dx.doi.org/10.1371/journal.pone.0253828.
Pełny tekst źródłaEfferson, Clay L., Naotake Tsuda, Kouichiro Kawano, et al. "Prostate Tumor Cells Infected with a Recombinant Influenza Virus Expressing a Truncated NS1 Protein Activate Cytolytic CD8+ Cells To Recognize Noninfected Tumor Cells." Journal of Virology 80, no. 1 (2006): 383–94. http://dx.doi.org/10.1128/jvi.80.1.383-394.2006.
Pełny tekst źródłaKovalenko, P. L., and M. D. Basson. "Exogenous Schlafen 12 Expression In The Lncap Prostate Cancer Cell Line Modulates Cell Differentiation." Journal of Surgical Research 186, no. 2 (2014): 683. http://dx.doi.org/10.1016/j.jss.2013.11.949.
Pełny tekst źródłaGonen, Ceren. "PMA Induction to Prostate Cancer Cell Lines: DU145 and LNCAP." Journal of Biomedical Engineering and Medical Imaging 11, no. 5 (2024): 86–94. https://doi.org/10.14738/bjhmr.115.17644.
Pełny tekst źródłaChouinard, Sarah, Olivier Barbier, and Alain Bélanger. "UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 Enzymes Are Major Determinants of the Androgen Response in Prostate Cancer LNCaP Cells." Journal of Biological Chemistry 282, no. 46 (2007): 33466–74. http://dx.doi.org/10.1074/jbc.m703370200.
Pełny tekst źródła